drugset / Trial / NCT02840617

ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes

NCT02840617

NaSingle-groupOpen-labelDiagnostic

Summary

This study aims to evaluate the feasibility of indocyanine green (ICG)-based fluorescence imaging in the detection of prostate tumors and metastatic lymph nodes. By correlating the ICG fluorescence patterns with pathologically confirmed tumor and nodal status, it would be possible to use fluorescence navigation system in helping prostate biopsy and lymph node dissection in the future.

Timeline

Start
2016-03
Primary completion
2018-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent 0.4 mg/kg Intravenous

Indications